Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIT in the Treatment of Pain Related to Pancreatic Cancer
NCT07733427Not yet recruiting
- Sponsor
- Clinique Bizet
- Start
- Sep 2026
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Open-label, single-arm trial of morphine, ziconotide and ropivacaine in pancreatic cancer (PC), sponsored by Clinique Bizet. Primary endpoint: Edmonton Symptom Assessment System - Pain Subscore at 12 months. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
morphineziconotideropivacaine
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT07733427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07733427.